UniProt ID | WRIP1_HUMAN | |
---|---|---|
UniProt AC | Q96S55 | |
Protein Name | ATPase WRNIP1 | |
Gene Name | WRNIP1 {ECO:0000312|HGNC:HGNC:20876} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 665 | |
Subcellular Localization | Nucleus . Cytoplasm . Colocalizes with WRN in granular structures in the nucleus. | |
Protein Description | Functions as a modulator of initiation or reinitiation events during DNA polymerase delta-mediated DNA synthesis. In the presence of ATP, stimulation of DNA polymerase delta-mediated DNA synthesis is decreased. Plays also a role in the innate immune defense against viruses. Stabilizes the RIG-I/DDX58 dsRNA interaction and promotes RIG-I/DDX58 'Lys-63'-linked polyubiquitination. In turn, RIG-I/DDX58 transmits the signal through mitochondrial MAVS.. | |
Protein Sequence | MEVSGPEDDPFLSQLHQVQCPVCQQMMPAAHINSHLDRCLLLHPAGHAEPAAGSHRAGERAKGPSPPGAKRRRLSESSALKQPATPTAAESSEGEGEEGDDGGETESRESYDAPPTPSGARLIPDFPVARSSSPGRKGSGKRPAAAAAAGSASPRSWDEAEAQEEEEAVGDGDGDGDADADGEDDPGHWDADAAEAATAFGASGGGRPHPRALAAEEIRQMLQGKPLADTMRPDTLQDYFGQSKAVGQDTLLRSLLETNEIPSLILWGPPGCGKTTLAHIIASNSKKHSIRFVTLSATNAKTNDVRDVIKQAQNEKSFFKRKTILFIDEIHRFNKSQQDTFLPHVECGTITLIGATTENPSFQVNAALLSRCRVIVLEKLPVEAMVTILMRAINSLGIHVLDSSRPTDPLSHSSNSSSEPAMFIEDKAVDTLAYLSDGDARAGLNGLQLAVLARLSSRKMFCKKSGQSYSPSRVLITENDVKEGLQRSHILYDRAGEEHYNCISALHKSMRGSDQNASLYWLARMLEGGEDPLYVARRLVRFASEDIGLADPSALTQAVAAYQGCHFIGMPECEVLLAQCVVYFARAPKSIEVYSAYNNVKACLRNHQGPLPPVPLHLRNAPTRLMKDLGYGKGYKYNPMYSEPVDQEYLPEELRGVDFFKQRRC | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Phosphorylation | ----MEVSGPEDDPF ----CCCCCCCCCHH | 35.01 | 28348404 | |
54 | Phosphorylation | HAEPAAGSHRAGERA CCCCCCCCCCCHHHC | 12.69 | 28348404 | |
62 | Ubiquitination | HRAGERAKGPSPPGA CCCHHHCCCCCCCCH | 77.04 | 27667366 | |
65 | Phosphorylation | GERAKGPSPPGAKRR HHHCCCCCCCCHHHH | 53.01 | 25159151 | |
66 (in isoform 3) | Ubiquitination | - | 34.18 | 21890473 | |
70 | Acetylation | GPSPPGAKRRRLSES CCCCCCHHHHCCCCC | 52.96 | 25953088 | |
70 | Ubiquitination | GPSPPGAKRRRLSES CCCCCCHHHHCCCCC | 52.96 | 21906983 | |
70 (in isoform 1) | Ubiquitination | - | 52.96 | 21890473 | |
70 (in isoform 2) | Ubiquitination | - | 52.96 | 21890473 | |
75 | Phosphorylation | GAKRRRLSESSALKQ CHHHHCCCCCCCCCC | 33.35 | 29255136 | |
77 | Phosphorylation | KRRRLSESSALKQPA HHHCCCCCCCCCCCC | 19.96 | 29255136 | |
78 | Phosphorylation | RRRLSESSALKQPAT HHCCCCCCCCCCCCC | 33.30 | 29255136 | |
81 | Sumoylation | LSESSALKQPATPTA CCCCCCCCCCCCCCC | 54.69 | - | |
81 | Ubiquitination | LSESSALKQPATPTA CCCCCCCCCCCCCCC | 54.69 | 17550899 | |
81 (in isoform 3) | Ubiquitination | - | 54.69 | 21890473 | |
85 | Phosphorylation | SALKQPATPTAAESS CCCCCCCCCCCCCCC | 28.05 | 27273156 | |
87 | Phosphorylation | LKQPATPTAAESSEG CCCCCCCCCCCCCCC | 33.86 | 23927012 | |
90 (in isoform 3) | Ubiquitination | - | 52.94 | 21890473 | |
91 | Phosphorylation | ATPTAAESSEGEGEE CCCCCCCCCCCCCCC | 29.03 | 23401153 | |
92 | Phosphorylation | TPTAAESSEGEGEEG CCCCCCCCCCCCCCC | 40.92 | 27273156 | |
96 (in isoform 3) | Ubiquitination | - | 49.46 | 21890473 | |
98 (in isoform 4) | Ubiquitination | - | 77.95 | 21890473 | |
105 | Phosphorylation | EGDDGGETESRESYD CCCCCCCCCCCCCCC | 42.40 | 28450419 | |
107 | Phosphorylation | DDGGETESRESYDAP CCCCCCCCCCCCCCC | 49.09 | 28450419 | |
110 | Phosphorylation | GETESRESYDAPPTP CCCCCCCCCCCCCCC | 27.48 | 29255136 | |
111 | Phosphorylation | ETESRESYDAPPTPS CCCCCCCCCCCCCCC | 16.03 | 29255136 | |
116 | Phosphorylation | ESYDAPPTPSGARLI CCCCCCCCCCCCCCC | 29.09 | 29255136 | |
118 | Phosphorylation | YDAPPTPSGARLIPD CCCCCCCCCCCCCCC | 47.79 | 30266825 | |
124 (in isoform 4) | Ubiquitination | - | 41.61 | 21890473 | |
131 | Phosphorylation | PDFPVARSSSPGRKG CCCCCCCCCCCCCCC | 25.98 | 22199227 | |
132 | Phosphorylation | DFPVARSSSPGRKGS CCCCCCCCCCCCCCC | 34.69 | 22199227 | |
133 | Phosphorylation | FPVARSSSPGRKGSG CCCCCCCCCCCCCCC | 32.40 | 22199227 | |
137 | Ubiquitination | RSSSPGRKGSGKRPA CCCCCCCCCCCCCCH | 64.44 | 22817900 | |
139 | Phosphorylation | SSPGRKGSGKRPAAA CCCCCCCCCCCCHHH | 44.14 | 23403867 | |
141 | Acetylation | PGRKGSGKRPAAAAA CCCCCCCCCCHHHHH | 57.83 | 25953088 | |
141 | Ubiquitination | PGRKGSGKRPAAAAA CCCCCCCCCCHHHHH | 57.83 | 17550899 | |
151 | Phosphorylation | AAAAAAGSASPRSWD HHHHHCCCCCCCCCC | 22.35 | 29255136 | |
153 | Phosphorylation | AAAAGSASPRSWDEA HHHCCCCCCCCCCHH | 23.65 | 29255136 | |
156 | Phosphorylation | AGSASPRSWDEAEAQ CCCCCCCCCCHHHHH | 42.11 | 28348404 | |
203 | Phosphorylation | AATAFGASGGGRPHP HHHHHCCCCCCCCCH | 38.05 | 24275569 | |
217 (in isoform 4) | Ubiquitination | - | 38.45 | 21890473 | |
225 | Ubiquitination | IRQMLQGKPLADTMR HHHHHCCCCCHHHCC | 24.73 | 21890473 | |
225 | Ubiquitination | IRQMLQGKPLADTMR HHHHHCCCCCHHHCC | 24.73 | 23000965 | |
225 (in isoform 1) | Ubiquitination | - | 24.73 | 21890473 | |
225 (in isoform 2) | Ubiquitination | - | 24.73 | 21890473 | |
239 | Phosphorylation | RPDTLQDYFGQSKAV CCCHHHHHHCCCCCC | 9.17 | - | |
243 (in isoform 4) | Ubiquitination | - | 23.98 | 21890473 | |
244 | Ubiquitination | QDYFGQSKAVGQDTL HHHHCCCCCCCHHHH | 38.92 | 21963094 | |
244 (in isoform 2) | Ubiquitination | - | 38.92 | - | |
249 (in isoform 4) | Ubiquitination | - | 33.13 | 21890473 | |
250 | Phosphorylation | SKAVGQDTLLRSLLE CCCCCHHHHHHHHHH | 21.58 | 27067055 | |
252 (in isoform 4) | Ubiquitination | - | 3.67 | 21890473 | |
262 (in isoform 3) | Ubiquitination | - | 19.53 | 21890473 | |
272 | Glutathionylation | ILWGPPGCGKTTLAH EEECCCCCCHHHHHH | 6.61 | 22555962 | |
277 (in isoform 4) | Ubiquitination | - | 3.85 | 21890473 | |
286 | Ubiquitination | HIIASNSKKHSIRFV HHHHCCCCCCEEEEE | 59.77 | 21890473 | |
286 | Neddylation | HIIASNSKKHSIRFV HHHHCCCCCCEEEEE | 59.77 | 32015554 | |
286 | Ubiquitination | HIIASNSKKHSIRFV HHHHCCCCCCEEEEE | 59.77 | 21906983 | |
286 (in isoform 1) | Ubiquitination | - | 59.77 | 21890473 | |
286 (in isoform 2) | Ubiquitination | - | 59.77 | 21890473 | |
287 | Ubiquitination | IIASNSKKHSIRFVT HHHCCCCCCEEEEEE | 42.26 | 22817900 | |
288 (in isoform 3) | Ubiquitination | - | 31.99 | 21890473 | |
301 | Ubiquitination | TLSATNAKTNDVRDV EEECCCCCCCCHHHH | 50.35 | 21890473 | |
301 | 2-Hydroxyisobutyrylation | TLSATNAKTNDVRDV EEECCCCCCCCHHHH | 50.35 | - | |
301 | Ubiquitination | TLSATNAKTNDVRDV EEECCCCCCCCHHHH | 50.35 | 27667366 | |
301 (in isoform 1) | Ubiquitination | - | 50.35 | 21890473 | |
301 (in isoform 2) | Ubiquitination | - | 50.35 | 21890473 | |
310 | Ubiquitination | NDVRDVIKQAQNEKS CCHHHHHHHHHCHHC | 39.15 | 21890473 | |
310 | Neddylation | NDVRDVIKQAQNEKS CCHHHHHHHHHCHHC | 39.15 | 32015554 | |
310 | Ubiquitination | NDVRDVIKQAQNEKS CCHHHHHHHHHCHHC | 39.15 | 27667366 | |
310 (in isoform 1) | Ubiquitination | - | 39.15 | 21890473 | |
310 (in isoform 2) | Ubiquitination | - | 39.15 | 21890473 | |
316 | Ubiquitination | IKQAQNEKSFFKRKT HHHHHCHHCHHHHHE | 61.18 | 21890473 | |
316 | Acetylation | IKQAQNEKSFFKRKT HHHHHCHHCHHHHHE | 61.18 | 25953088 | |
316 | Ubiquitination | IKQAQNEKSFFKRKT HHHHHCHHCHHHHHE | 61.18 | 27667366 | |
316 (in isoform 1) | Ubiquitination | - | 61.18 | 21890473 | |
316 (in isoform 2) | Ubiquitination | - | 61.18 | 21890473 | |
320 | Ubiquitination | QNEKSFFKRKTILFI HCHHCHHHHHEEEEH | 51.48 | 22817900 | |
322 | Ubiquitination | EKSFFKRKTILFIDE HHCHHHHHEEEEHHH | 40.27 | 17550899 | |
335 | Ubiquitination | DEIHRFNKSQQDTFL HHHHHCCHHHCCCCC | 47.10 | 17550899 | |
336 (in isoform 2) | Phosphorylation | - | 33.89 | 21406692 | |
345 (in isoform 2) | Phosphorylation | - | 6.51 | 21406692 | |
370 | Phosphorylation | QVNAALLSRCRVIVL HHHHHHHHCCEEEEE | 30.13 | - | |
381 (in isoform 3) | Ubiquitination | - | 32.73 | 21890473 | |
387 | Phosphorylation | LPVEAMVTILMRAIN CCHHHHHHHHHHHHH | 8.70 | 24043423 | |
395 | Phosphorylation | ILMRAINSLGIHVLD HHHHHHHHCCCEECC | 23.12 | 24043423 | |
403 | Phosphorylation | LGIHVLDSSRPTDPL CCCEECCCCCCCCCC | 24.88 | 24043423 | |
404 | Phosphorylation | GIHVLDSSRPTDPLS CCEECCCCCCCCCCC | 41.78 | 24043423 | |
407 (in isoform 3) | Ubiquitination | - | 49.49 | 21890473 | |
413 | Phosphorylation | PTDPLSHSSNSSSEP CCCCCCCCCCCCCCC | 28.04 | 24247654 | |
413 (in isoform 3) | Ubiquitination | - | 28.04 | 21890473 | |
416 (in isoform 3) | Ubiquitination | - | 36.87 | 21890473 | |
434 | Phosphorylation | KAVDTLAYLSDGDAR CHHHEEECCCCCCHH | 15.17 | 29449344 | |
436 | Phosphorylation | VDTLAYLSDGDARAG HHEEECCCCCCHHCC | 27.20 | 29449344 | |
439 | Ubiquitination | LAYLSDGDARAGLNG EECCCCCCHHCCCCH | 37.56 | 22505724 | |
441 (in isoform 3) | Ubiquitination | - | 33.65 | 21890473 | |
457 | Ubiquitination | AVLARLSSRKMFCKK HHHHHHHCCCCCCCC | 40.28 | 21890473 | |
457 | Ubiquitination | AVLARLSSRKMFCKK HHHHHHHCCCCCCCC | 40.28 | 23000965 | |
457 (in isoform 2) | Ubiquitination | - | 40.28 | 21890473 | |
464 | Ubiquitination | SRKMFCKKSGQSYSP CCCCCCCCCCCCCCC | 62.08 | 22505724 | |
465 | Phosphorylation | RKMFCKKSGQSYSPS CCCCCCCCCCCCCCC | 27.79 | 29396449 | |
468 | Phosphorylation | FCKKSGQSYSPSRVL CCCCCCCCCCCCCEE | 30.97 | 25159151 | |
469 | Phosphorylation | CKKSGQSYSPSRVLI CCCCCCCCCCCCEEE | 19.40 | 29396449 | |
470 | Phosphorylation | KKSGQSYSPSRVLIT CCCCCCCCCCCEEEE | 22.96 | 21815630 | |
472 | Phosphorylation | SGQSYSPSRVLITEN CCCCCCCCCEEEECC | 29.13 | 28985074 | |
477 | Phosphorylation | SPSRVLITENDVKEG CCCCEEEECCHHHHH | 25.28 | 26074081 | |
482 | Sumoylation | LITENDVKEGLQRSH EEECCHHHHHHHHHC | 49.26 | - | |
482 | Sumoylation | LITENDVKEGLQRSH EEECCHHHHHHHHHC | 49.26 | 28112733 | |
482 | Ubiquitination | LITENDVKEGLQRSH EEECCHHHHHHHHHC | 49.26 | 23000965 | |
482 (in isoform 1) | Ubiquitination | - | 49.26 | 21890473 | |
483 | Ubiquitination | ITENDVKEGLQRSHI EECCHHHHHHHHHCC | 66.05 | 21890473 | |
483 | Ubiquitination | ITENDVKEGLQRSHI EECCHHHHHHHHHCC | 66.05 | 23000965 | |
483 (in isoform 2) | Ubiquitination | - | 66.05 | 21890473 | |
500 | Phosphorylation | DRAGEEHYNCISALH CCCCHHHHHHHHHHH | 18.27 | 25884760 | |
504 | Phosphorylation | EEHYNCISALHKSMR HHHHHHHHHHHHHHC | 27.29 | 28152594 | |
508 | Ubiquitination | NCISALHKSMRGSDQ HHHHHHHHHHCCCCH | 46.96 | 23000965 | |
508 (in isoform 1) | Ubiquitination | - | 46.96 | 21890473 | |
511 | Methylation | SALHKSMRGSDQNAS HHHHHHHCCCCHHHH | 48.86 | 115920089 | |
534 | Phosphorylation | EGGEDPLYVARRLVR HCCCCHHHHHHHHHH | 9.46 | 20090780 | |
562 | Phosphorylation | LTQAVAAYQGCHFIG HHHHHHHHCCCCCCC | 8.83 | 22817900 | |
576 | Ubiquitination | GMPECEVLLAQCVVY CCCHHHHHHHHHHHH | 1.21 | 21890473 | |
576 | Ubiquitination | GMPECEVLLAQCVVY CCCHHHHHHHHHHHH | 1.21 | 23000965 | |
576 (in isoform 2) | Ubiquitination | - | 1.21 | 21890473 | |
594 | Phosphorylation | APKSIEVYSAYNNVK CCCCEEHHHHHCCHH | 3.77 | 28152594 | |
595 | Phosphorylation | PKSIEVYSAYNNVKA CCCEEHHHHHCCHHH | 29.47 | 28152594 | |
597 | Phosphorylation | SIEVYSAYNNVKACL CEEHHHHHCCHHHHH | 11.00 | 28152594 | |
601 | Ubiquitination | YSAYNNVKACLRNHQ HHHHCCHHHHHHHCC | 35.19 | 23000965 | |
601 (in isoform 1) | Ubiquitination | - | 35.19 | 21890473 | |
602 | Ubiquitination | SAYNNVKACLRNHQG HHHCCHHHHHHHCCC | 8.03 | 21890473 | |
602 | Ubiquitination | SAYNNVKACLRNHQG HHHCCHHHHHHHCCC | 8.03 | 23000965 | |
602 (in isoform 2) | Ubiquitination | - | 8.03 | 21890473 | |
608 | Ubiquitination | KACLRNHQGPLPPVP HHHHHHCCCCCCCCC | 59.76 | 21890473 | |
608 | Acetylation | KACLRNHQGPLPPVP HHHHHHCCCCCCCCC | 59.76 | 19608861 | |
608 | Ubiquitination | KACLRNHQGPLPPVP HHHHHHCCCCCCCCC | 59.76 | 23000965 | |
608 (in isoform 2) | Ubiquitination | - | 59.76 | 21890473 | |
611 | Ubiquitination | LRNHQGPLPPVPLHL HHHCCCCCCCCCCHH | 10.81 | 21890473 | |
611 | Ubiquitination | LRNHQGPLPPVPLHL HHHCCCCCCCCCCHH | 10.81 | 23000965 | |
611 (in isoform 2) | Ubiquitination | - | 10.81 | 21890473 | |
627 | Ubiquitination | NAPTRLMKDLGYGKG CCCCHHHHHHCCCCC | 55.16 | 23000965 | |
627 (in isoform 1) | Ubiquitination | - | 55.16 | 21890473 | |
631 | Phosphorylation | RLMKDLGYGKGYKYN HHHHHHCCCCCCCCC | 23.98 | 22817900 | |
633 | Acetylation | MKDLGYGKGYKYNPM HHHHCCCCCCCCCCC | 51.05 | 19608861 | |
633 | Ubiquitination | MKDLGYGKGYKYNPM HHHHCCCCCCCCCCC | 51.05 | 23000965 | |
633 (in isoform 1) | Ubiquitination | - | 51.05 | 21890473 | |
635 | Phosphorylation | DLGYGKGYKYNPMYS HHCCCCCCCCCCCCC | 17.49 | 22817900 | |
636 | Ubiquitination | LGYGKGYKYNPMYSE HCCCCCCCCCCCCCC | 47.41 | 21890473 | |
636 | Acetylation | LGYGKGYKYNPMYSE HCCCCCCCCCCCCCC | 47.41 | 25953088 | |
636 | Neddylation | LGYGKGYKYNPMYSE HCCCCCCCCCCCCCC | 47.41 | 32015554 | |
636 | Ubiquitination | LGYGKGYKYNPMYSE HCCCCCCCCCCCCCC | 47.41 | 23000965 | |
636 (in isoform 1) | Ubiquitination | - | 47.41 | 21890473 | |
636 (in isoform 2) | Ubiquitination | - | 47.41 | 21890473 | |
637 | Phosphorylation | GYGKGYKYNPMYSEP CCCCCCCCCCCCCCC | 18.93 | 27642862 | |
641 | Phosphorylation | GYKYNPMYSEPVDQE CCCCCCCCCCCCCHH | 15.90 | 27642862 | |
655 | Methylation | EYLPEELRGVDFFKQ HHCCHHHCCCCCHHH | 46.50 | 115920093 | |
661 | Neddylation | LRGVDFFKQRRC--- HCCCCCHHHCCC--- | 42.78 | 32015554 | |
661 | Ubiquitination | LRGVDFFKQRRC--- HCCCCCHHHCCC--- | 42.78 | 23000965 | |
661 (in isoform 1) | Ubiquitination | - | 42.78 | 21890473 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of WRIP1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of WRIP1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of WRIP1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
WRN_HUMAN | WRN | physical | 11301316 | |
UBP11_HUMAN | USP11 | physical | 19615732 | |
NU107_HUMAN | NUP107 | physical | 20676042 | |
RAD18_HUMAN | RAD18 | physical | 19556710 | |
WRIP1_HUMAN | WRNIP1 | physical | 15670210 | |
DPOD1_HUMAN | POLD1 | physical | 15670210 | |
TIF1B_HUMAN | TRIM28 | physical | 22863883 | |
UBC_HUMAN | UBC | physical | 17550899 | |
UBC_HUMAN | UBC | physical | 25872870 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-633, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-85; SER-91; SER-92;THR-116 AND TYR-534, AND MASS SPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-151 AND SER-153, ANDMASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-91 AND SER-92, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75; THR-85; SER-91;SER-92 AND THR-116, AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-534 AND TYR-562, ANDMASS SPECTROMETRY. | |
Ubiquitylation | |
Reference | PubMed |
"Werner helicase-interacting protein 1 binds polyubiquitin via itszinc finger domain."; Bish R.A., Myers M.P.; J. Biol. Chem. 282:23184-23193(2007). Cited for: SUMOYLATION, UBIQUITINATION AT LYS-81; LYS-141; LYS-225; LYS-301;LYS-310; LYS-316; LYS-322; LYS-335; LYS-482; LYS-627; LYS-633 ANDLYS-636, AND DOMAIN UBZ-TYPE ZINC FINGER. |